Stockreport

Immune Pharma inks convertible debt deal at $1.75; shares slump 45% [Seeking Alpha]

IMMUNE PHARMACEUTICALS INC NE  (IMNP) 
US:NASDAQ Investor Relations: immunepharma.com/investor-relations
PDF Immune Pharmaceuticals ( IMNP ) enters into an agreement with institutional investors for the sale of $858K aggregate principal amount of convertible debentur [Read more]